Back to News
Market Impact: 0.18

Wall Street Analysts Believe Alkermes (ALKS) Could Rally 29.14%: Here's is How to Trade

ALKS
Analyst EstimatesAnalyst InsightsCompany FundamentalsHealthcare & Biotech

Alkermes (ALKS) has a consensus price target implying 29.1% upside, with the article highlighting improving earnings estimate revisions as a potential near-term catalyst. The commentary is modestly supportive but largely analytical, noting that price targets alone are often unreliable. No operational update or new company-specific event was reported.

Analysis

Alkermes (ALKS) has a consensus price target implying 29.1% upside, with the article highlighting improving earnings estimate revisions as a potential near-term catalyst. The commentary is modestly supportive but largely analytical, noting that price targets alone are often unreliable. No operational update or new company-specific event was reported.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.20

Ticker Sentiment

ALKS0.20